i-SENS Highlights Connected Diagnostic Systems at MEDICA 2025
Posted on 17 Nov 2025
i-SENS is presenting its latest in vitro diagnostic innovations at MEDICA 2025, highlighting connected testing platforms for clinical and near-patient applications. At Hall 3, Booth B51, i-SENS is showcasing its i‑SmartCare 10 and i‑Smart 30 Pro systems alongside additional point‑of‑care (POC) analyzers intended to provide precise, efficient testing across hospital laboratories and near‑patient workflows.
The i-SmartCare 10 is a blood gas, electrolyte, and metabolites analyzer optimized for POC use. The compact and lightweight analyzer features a high-capacity battery that supports two hours of mobile, continuous testing, plus an easy-to-manage all-in-one cartridge system. The i-Smart 30 Pro is an electrolyte analyzer that measures Na+, K+, and CI- concentrations, reporting results in 35 seconds on a color screen. Added benefits include an all-in-one cartridge that can be used for four weeks, battery power for two hours, and fast and error-free data entry using a barcode scanner.

The company will also feature the CareSens Air Continuous Glucose Monitoring System (CGMS). CareSens Air CGM is a 15-day, all-in-one sensor that provides real-time glucose monitoring, with data easily accessible through the CareSens app. The sensor is just 5 mm thick and weighs only 4.5 g.. Also on display at the i-SENS booth is a wide variety of CareSens Blood Glucose Monitoring System (BGMS) models, designed for accuracy, ease of use, and reliability in diverse care environments.
i-SENS’s participation at MEDICA 2025 underscores the company’s commitment to advancing smart, connected diagnostics that enhance clinical decision-making and improve patient outcomes. By continuously developing innovative and accessible solutions, i-SENS strives to support healthcare professionals and contribute to a more connected, data-driven future of care.
Related Links:
i-SENS







 assay.jpg)
